Yes, estrogen is both stored in and produced by fat tissue. Fat cells don’t just passively hold onto estrogen the way they store energy. They actively manufacture it by converting other hormones, and they store it in a chemically inactive form that can be reactivated later. This two-way relationship between fat and estrogen has real consequences for health, body composition, and disease risk in both women and men.
How Fat Tissue Produces Estrogen
Fat cells contain an enzyme called aromatase that converts androgens (like testosterone and androstenedione) into estrogens. This is the same basic conversion that happens in the ovaries, but fat tissue does it on a smaller, more localized scale. Aromatase in fat converts testosterone into estradiol (the most potent form of estrogen) and androstenedione into estrone (a weaker form). The more fat tissue you carry, the more aromatase activity you have, and the more estrogen your body produces outside the ovaries or testes.
Fat tissue can also convert one type of estrogen into another. Estradiol can be oxidized into estrone within fat cells through a separate enzymatic process. This matters because estrone is less biologically active, giving the body a way to dial estrogen’s effects up or down locally.
How Estrogen Gets Stored in Fat
Estrogen is a steroid hormone, which means it’s built from cholesterol and dissolves easily in fat. This lipophilic (fat-loving) property is part of why it accumulates in fatty tissue in the first place. But the storage mechanism goes beyond simple dissolution.
Fat cells store estradiol by attaching it to fatty acid chains, creating what’s called a fatty acyl ester. In this esterified form, estradiol is biologically inactive. It can’t bind to estrogen receptors or trigger any of estrogen’s usual effects. Think of it like a hormone in cold storage. When the body needs it, enzymes can strip off the fatty acid attachment and release active estradiol back into circulation. The balance between esterification (locking estrogen away) and hydrolysis (releasing it) acts as a local control system for how much active estrogen is available at any given time.
Body Fat and Estrogen Levels
The relationship between body fat and circulating estrogen isn’t a simple straight line. In premenopausal women, research on complete menstrual cycles found that women with very low body fat and women with very high body fat both had lower estradiol levels than women in the low-to-average range. Among women with very low to average body fat, a 10% increase in body fat corresponded to roughly a 5 to 7 pmol/L increase in estradiol. But at higher body fat levels, this pattern reversed, creating a curve rather than a steady climb.
After menopause, the picture changes significantly. Once the ovaries stop producing estrogen, fat tissue becomes the body’s primary estrogen source. This is why body fat percentage matters so much for postmenopausal hormone levels. Women with more adipose tissue maintain higher circulating estrogen than leaner postmenopausal women, which carries both benefits (like some protection against bone loss) and risks.
Visceral Fat vs. Subcutaneous Fat
Not all fat behaves the same way. Visceral fat, the type that surrounds your organs deep in the abdomen, is more metabolically active and more problematic than subcutaneous fat (the layer just under your skin). Visceral fat is more prone to inflammation, produces more inflammatory signaling molecules, and tends to develop reduced blood supply and increased scarring as it expands. While both types of fat contain aromatase and produce estrogen, visceral fat’s inflammatory profile compounds the metabolic disruption that excess estrogen production can cause.
Why This Matters for Cancer Risk
The estrogen produced by fat tissue is a key reason obesity raises the risk of certain cancers, particularly breast cancer after menopause. More than 75% of breast cancers are hormone-dependent tumors that express estrogen receptors and grow in response to estrogen. In postmenopausal women, excess body fat is specifically linked to increased risk of these estrogen-receptor-positive cancers.
A meta-analysis found that every 5-point increase in BMI was associated with roughly a 2% increase in breast cancer risk for postmenopausal women. That may sound modest, but it compounds across the wide BMI range seen in the general population. Interestingly, higher BMI in premenopausal women appears to have a slight protective effect against breast cancer, likely because the hormonal dynamics work differently when the ovaries are still the dominant estrogen source.
Effects on Men
Men produce estrogen too, and fat tissue is a major site of that production. Aromatase in male fat tissue converts circulating testosterone into estradiol, which means men with more body fat tend to convert more of their testosterone into estrogen. Researchers have confirmed increased urinary estrogen concentrations in obese men and have directly measured aromatase expression in their fat tissue.
This conversion process is the primary mechanism behind gynecomastia (breast tissue development) in overweight and obese men. When aromatase activity in fat tissue ramps up, serum and local breast estrogen concentrations rise enough to stimulate breast tissue growth. The same process helps explain why gynecomastia becomes more common in men over 60: total body fat tends to increase with age, testosterone levels decline, and aromatase activity in existing fat tissue may actually increase independently. The combination creates a hormonal environment that favors estrogen’s effects.
That said, most obese men don’t have dramatically elevated estrogen levels in blood tests, which suggests that local estrogen production within specific fat deposits may matter more than what shows up in a standard blood draw. The estrogen made in breast-area fat tissue, for example, can act on nearby cells without ever reaching high enough concentrations to register as abnormal in circulation.
How Estrogen Influences Where Fat Accumulates
The relationship runs both directions. Fat tissue produces and stores estrogen, but estrogen also influences where your body deposits fat. Estradiol and testosterone both appear to promote fat breakdown in the abdominal region, which is one reason premenopausal women tend to store fat in the hips and thighs rather than the belly. After menopause, when estrogen levels drop, fat distribution often shifts toward the abdomen, a pattern associated with higher cardiovascular and metabolic risk.
Progesterone, meanwhile, appears to increase the activity of fat-storing enzymes in the thigh and hip area. These hormonal influences on fat placement help explain why body shape often changes noticeably during menopause, pregnancy, and other periods of major hormonal shift, even when total body weight stays relatively stable.